Titre : Mitomycine

Mitomycine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Biomedical Technology
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mitomycine : Questions médicales les plus fréquentes", "headline": "Mitomycine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mitomycine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mitomycine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mitomycines", "url": "https://questionsmedicales.fr/mesh/D008937", "about": { "@type": "MedicalCondition", "name": "Mitomycines", "code": { "@type": "MedicalCode", "code": "D008937", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.473.412.249" } } }, "about": { "@type": "MedicalCondition", "name": "Mitomycine", "alternateName": "Mitomycin", "code": { "@type": "MedicalCode", "code": "D016685", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elise Champeil", "url": "https://questionsmedicales.fr/author/Elise%20Champeil", "affiliation": { "@type": "Organization", "name": "John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA; The Graduate Center of the City University of New York, New York, NY 10016, USA. Electronic address: echampeil@jjay.cuny.edu." } }, { "@type": "Person", "name": "Owen Zacarias", "url": "https://questionsmedicales.fr/author/Owen%20Zacarias", "affiliation": { "@type": "Organization", "name": "Department of Sciences, John Jay College of Criminal Justice, New York, NY 10019, United States." } }, { "@type": "Person", "name": "Maggie Zheng", "url": "https://questionsmedicales.fr/author/Maggie%20Zheng", "affiliation": { "@type": "Organization", "name": "John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: maggie.zheng@jjay.cuny.edu." } }, { "@type": "Person", "name": "Timothy Snyder", "url": "https://questionsmedicales.fr/author/Timothy%20Snyder", "affiliation": { "@type": "Organization", "name": "John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: timothy.snyder@jjay.cuny.edu." } }, { "@type": "Person", "name": "Gloria Proni", "url": "https://questionsmedicales.fr/author/Gloria%20Proni", "affiliation": { "@type": "Organization", "name": "John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: gproni@jjay.cuny.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies?", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37019064", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vhri.2023.02.002" } }, { "@type": "ScholarlyArticle", "name": "Adaptive Health Technology Assessment: A Scoping Review of Methods.", "datePublished": "2023-06-05", "url": "https://questionsmedicales.fr/article/37285917", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jval.2023.05.017" } }, { "@type": "ScholarlyArticle", "name": "Living Health Technology Assessment: Issues, Challenges and Opportunities.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36652184", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40273-022-01229-4" } }, { "@type": "ScholarlyArticle", "name": "The economic imperatives for technology enabled wellness centered healthcare.", "datePublished": "2022-08-03", "url": "https://questionsmedicales.fr/article/35922479", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1057/s41271-022-00356-8" } }, { "@type": "ScholarlyArticle", "name": "Bibliometric Analysis of Health Technology Research: 1990~2020.", "datePublished": "2022-07-25", "url": "https://questionsmedicales.fr/article/35897415", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19159044" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Indoles", "item": "https://questionsmedicales.fr/mesh/D007211" }, { "@type": "ListItem", "position": 6, "name": "Indolequinones", "item": "https://questionsmedicales.fr/mesh/D045563" }, { "@type": "ListItem", "position": 7, "name": "Mitomycines", "item": "https://questionsmedicales.fr/mesh/D008937" }, { "@type": "ListItem", "position": 8, "name": "Mitomycine", "item": "https://questionsmedicales.fr/mesh/D016685" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mitomycine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mitomycine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mitomycine", "description": "Comment la mitomycine est-elle administrée ?\nQuels tests sont nécessaires avant traitement ?\nLa mitomycine est-elle utilisée pour tous les cancers ?\nQuels marqueurs tumoraux sont surveillés ?\nY a-t-il des contre-indications au traitement ?", "url": "https://questionsmedicales.fr/mesh/D016685?mesh_terms=Biomedical+Technology&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mitomycine", "description": "Quels sont les effets secondaires courants ?\nLa mitomycine cause-t-elle des douleurs ?\nQuels symptômes indiquent une réaction allergique ?\nPeut-elle affecter le système immunitaire ?\nQuels signes de toxicité doivent alerter ?", "url": "https://questionsmedicales.fr/mesh/D016685?mesh_terms=Biomedical+Technology&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mitomycine", "description": "Comment minimiser les effets secondaires ?\nDes vaccinations sont-elles nécessaires ?\nComment éviter les infections pendant le traitement ?\nY a-t-il des recommandations alimentaires ?\nComment gérer le stress pendant le traitement ?", "url": "https://questionsmedicales.fr/mesh/D016685?mesh_terms=Biomedical+Technology&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mitomycine", "description": "La mitomycine est-elle utilisée seule ?\nQuelle est la durée du traitement ?\nComment surveiller l'efficacité du traitement ?\nQuels soins de soutien sont recommandés ?\nY a-t-il des interactions médicamenteuses ?", "url": "https://questionsmedicales.fr/mesh/D016685?mesh_terms=Biomedical+Technology&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mitomycine", "description": "Quelles sont les complications possibles ?\nLa mitomycine peut-elle causer des cancers secondaires ?\nComment gérer une toxicité sévère ?\nQuels tests pour surveiller les complications ?\nY a-t-il des effets à long terme ?", "url": "https://questionsmedicales.fr/mesh/D016685?mesh_terms=Biomedical+Technology&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mitomycine", "description": "Qui est à risque d'effets secondaires ?\nLes antécédents de cancer augmentent-ils le risque ?\nLe tabagisme influence-t-il le traitement ?\nY a-t-il des facteurs génétiques à considérer ?\nL'âge influence-t-il la tolérance au traitement ?", "url": "https://questionsmedicales.fr/mesh/D016685?mesh_terms=Biomedical+Technology&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment la mitomycine est-elle administrée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La mitomycine est généralement administrée par injection intraveineuse ou intravésicale." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant traitement ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des examens d'imagerie sont souvent requis pour évaluer la santé du patient." } }, { "@type": "Question", "name": "La mitomycine est-elle utilisée pour tous les cancers ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle est principalement utilisée pour des cancers spécifiques comme le cancer de la vessie." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont surveillés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme le CA 19-9 peuvent être surveillés selon le type de cancer traité." } }, { "@type": "Question", "name": "Y a-t-il des contre-indications au traitement ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents d'allergies ou de maladies rénales peuvent être des contre-indications." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent nausées, vomissements, et fatigue." } }, { "@type": "Question", "name": "La mitomycine cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des douleurs abdominales ou des douleurs au site d'injection." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réaction allergique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, éruptions cutanées ou difficultés respiratoires peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Peut-elle affecter le système immunitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la mitomycine peut réduire les globules blancs, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quels signes de toxicité doivent alerter ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements inhabituels ou des ecchymoses peuvent indiquer une toxicité." } }, { "@type": "Question", "name": "Comment minimiser les effets secondaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hydratation et des médicaments antiémétiques peuvent aider à réduire les effets secondaires." } }, { "@type": "Question", "name": "Des vaccinations sont-elles nécessaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des vaccinations peuvent être recommandées pour prévenir les infections pendant le traitement." } }, { "@type": "Question", "name": "Comment éviter les infections pendant le traitement ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les foules et pratiquer une bonne hygiène peut aider à prévenir les infections." } }, { "@type": "Question", "name": "Y a-t-il des recommandations alimentaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et riche en nutriments est recommandée pour soutenir le traitement." } }, { "@type": "Question", "name": "Comment gérer le stress pendant le traitement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation et le soutien psychologique peuvent aider à gérer le stress." } }, { "@type": "Question", "name": "La mitomycine est-elle utilisée seule ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être utilisée seule ou en combinaison avec d'autres agents chimiothérapeutiques." } }, { "@type": "Question", "name": "Quelle est la durée du traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La durée varie selon le type de cancer, mais elle est souvent administrée sur plusieurs cycles." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des examens d'imagerie et des tests sanguins réguliers sont utilisés pour évaluer l'efficacité." } }, { "@type": "Question", "name": "Quels soins de soutien sont recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des soins de soutien comme la gestion de la douleur et des conseils nutritionnels sont recommandés." } }, { "@type": "Question", "name": "Y a-t-il des interactions médicamenteuses ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la mitomycine peut interagir avec d'autres médicaments, nécessitant une surveillance." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des infections, des saignements et des problèmes rénaux." } }, { "@type": "Question", "name": "La mitomycine peut-elle causer des cancers secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation de mitomycine peut augmenter le risque de cancers secondaires à long terme." } }, { "@type": "Question", "name": "Comment gérer une toxicité sévère ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation et un traitement symptomatique peuvent être nécessaires en cas de toxicité sévère." } }, { "@type": "Question", "name": "Quels tests pour surveiller les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins réguliers et des examens d'imagerie sont nécessaires pour surveiller les complications." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des effets à long terme peuvent inclure des problèmes pulmonaires ou rénaux, nécessitant un suivi." } }, { "@type": "Question", "name": "Qui est à risque d'effets secondaires ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées et celles avec des antécédents médicaux complexes sont plus à risque." } }, { "@type": "Question", "name": "Les antécédents de cancer augmentent-ils le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer peuvent augmenter le risque d'effets secondaires lors du traitement." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le traitement ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affecter l'efficacité du traitement et augmenter les risques d'effets secondaires." } }, { "@type": "Question", "name": "Y a-t-il des facteurs génétiques à considérer ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines variations génétiques peuvent influencer la réponse au traitement par mitomycine." } }, { "@type": "Question", "name": "L'âge influence-t-il la tolérance au traitement ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients plus âgés peuvent avoir une tolérance réduite aux effets de la mitomycine." } } ] } ] }

Sources (10000 au total)

Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies?

The introduction of digital health technologies (DHTs) that have the potential to improve health outcomes and lower the costs of healthcare services has seen an explosion in recent years. Indeed, the ... We examine the regulatory landscape, health technology assessment process, and reimbursement coverage determination for DHTs in Korea.... We identified the specific challenges and opportunities for reimbursement coverage of DHTs.... To ensure DHTs can be used effectively in medical practice, a more flexible and nontraditional approach to assessment, reimbursement, and payment determination is required....

Adaptive Health Technology Assessment: A Scoping Review of Methods.

Health technology assessment (HTA) is an established mechanism for explicit priority setting to support universal health coverage. However, full HTA requires significant time, data, and capacity for e... The objectives of this scoping review were to identify and map existing aHTA methods, and to assess their triggers, strengths, and weaknesses. This was done by searching HTA agencies' and networks' we... This review identified 20 countries and 1 HTA network with aHTA methods in the Americas, Europe, Africa, and South-East Asia. These methods have been characterized into 5 types: rapid reviews, rapid c... aHTA is used in many settings. It has potential to improve the efficiency of any priority-setting system, but needs to be better formalized to improve uptake, particularly for nascent HTA systems....

Requirements for building educational and care technology on heart failure.

to investigate the requirements for building an educational and care application about heart failure.... exploratory study, carried out with 15 people with heart failure and 19 family members/caregivers, assisted in a tertiary unit in the Brazilian Northeast. Individual semi-structured interviews were ca... two units of meaning emerged: "The plurality of care in heart failure" and "Expectations on the construction and use of educational and care technology for heart failure". The requirements involved th... requirements on educational and care technology were identified and will support the creation of an application that promotes care, aiming to obtain positive health outcomes....

Approaches to Evaluating Digital Health Technologies: Scoping Review.

Profound scientific evaluation of novel digital health technologies (DHTs) is key to enhance successful development and implementation. As such, we previously developed the eHealth evaluation cycle. T... The aim of this study is to develop a better understanding of the daily practice of the eHealth evaluation cycle. Therefore, the objectives are to conduct a structured analysis of literature data to a... We conducted a systematic literature search in PubMed including the MeSH term "telemedicine" in combination with a wide variety of evaluation approaches. Original peer-reviewed studies published in th... We included 824 studies after 1583 titles and abstracts were screened. The majority of the evaluation studies focused on the effectiveness (impact; 304/824, 36.9%) study phase, whereas uptake (impleme... We composed the first comprehensive overview of the actual practice of implementing consecutive DHT evaluation study phases. We found that the study phases of the eHealth evaluation cycle are unequall...

Future health technology trends, policy, and governance perspective: the Turkish case.

Advanced health technologies that emerge with the development of technology have an impact on health systems. This study aimed to determine the effects of these technologies on Türkiye's health system... Interviews were conducted with senior managers, bureaucrats, policy-makers and decision-makers from seven different institutions on the subject. Content analysis was performed on the data obtained and... It was concluded that these technologies would not have a positive impact on two identified themes, a negative impact on seven themes and a predominant impact on five themes in Türkiye.... To adapt to the new health ecosystem in Türkiye, it is recommended to increase digital literacy, conduct economic evaluations of technologies, promote domestic production, ensure up-to-date follow-up,...